Allison Gomes

Dr. Allison Gomes


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2019 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
AGAllison Gomes
Allison Gomes
DHDeborah Hutcheon
Deborah Hutcheon
JZJane Ziegler
Jane Ziegler

12 October 2022 in Nutrition in Clinical Practice
Verified
Journal Article
Open access
CHCorey Hawes
Corey Hawes
AGAllison Gomes
Allison Gomes
LBLaura Byham‐Gray
Laura Byham‐Gray
SHStephanie Henderson
Stephanie Henderson
The objective of this study was to identify the use and impact of oral nutrition supplements (ONSs) and appetite stimulants on weight status among pediatric patients diagnosed with malignancy. We performed a literature search of trials using Medline PubMed, CINAHL, Web of Science Core Collection, Scopus, and Cochrane Database of Systematic Reviews and included all prospective studies except review articles and case‐reports/series that assessed ONSs or appetite stimulants among patients (0–20 years old) diagnosed with a pediatric malignancy. Databases were searched through May 17, 2022. There were six trials included with three studies related to ONS and the remaining on appetite stimulants. No studies that compared both ONS and appetite stimulants were found. To assess quality, we used the Risk of Bias in Nonrandomized Studies of Interventions and the Revised Cochrane Risk of Bias Tool for Randomized Trials depending on the study design. The studies all had pediatric patients diagnosed with a variety of malignancy types. All studies demonstrated improvement of weight status in the treatment group across various malignancy types. However, none of the studies addressed nutrition intakes outside of ONS consumption, compliance to ONSs, or frequency of ONS use. Despite the short durations (3–6 months) and significant differences in the timing of intervention initiation (ONS or appetite stimulants), these treatment modalities can improve weight status. Further research is needed to identify the best intervention for improving weight status.

18 May 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
AGAllison Gomes
Allison Gomes
RPRachael Patusco
Rachael Patusco
MCMei Chung
Mei Chung
MDMargaret R. Dreker
Margaret R. Dreker
LBLaura Byham‐Gray
Laura Byham‐Gray
JZJane Ziegler
Jane Ziegler

1 January 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
ACAnca Cunningham
Anca Cunningham
AGAllison Gomes
Allison Gomes
LMLingqiong Meng
Lingqiong Meng
SSSue Shapses
Sue Shapses
LBLaura Byham-Gray
Laura Byham-Gray
HSHamed Samavat
Hamed Samavat
Background: Excess adiposity induces low-grade inflammation, including increased C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Green tea contains epigallocatechin gallate (EGCG), with anti-inflammatory potential. EGCG metabolism is influenced by individual variations in catechol-O-methyltransferase (COMT) genotypes. Objectives: To evaluate the effect of green tea extract (GTE) supplementation on circulating inflammatory cytokines among postmenopausal women with overweight or obesity and differing COMT genotypes. Methods: This study is a secondary analysis of a random subset (N = 97) from the Minnesota Green Tea Trial (MGTT), a randomized double-blinded placebo-controlled trial. The intervention was a high-dose GTE supplement (843 ± 44 mg EGCG/day) or placebo for 1 year. Serum CRP, TNF-α, and IL-6 were measured at 0, 6, and 12 months. Absolute changes in inflammatory cytokines from baseline to month 12 were evaluated using linear mixed-effects models adjusted for age, body mass index (BMI), smoking history, physical activity, and vitamin supplement use. Results: The changes from month 0 to month 12 were not statistically different between the groups for any of the inflammatory cytokines measured. The overall treatment effect was not statistically significant for CRP (p = 0.24), IL-6 (p = 0.59), TNF-α (p = 0.36), nor for the interaction between treatment group and time (all Ps > 0.40). There was no significant interaction between treatment group and COMT genotype for the stated markers. Conclusions: A high-dose GTE supplement consumed daily for one year did not significantly decrease inflammatory cytokines among postmenopausal women with overweight or obesity. The COMT genotype did not modify the effects of GTE supplementation on inflammatory cytokines. Future studies with a larger sample size among those at high risk of systemic inflammation are warranted.

1 August 2020 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
AGAllison Gomes
Allison Gomes
CLCraig Lapin
Craig Lapin
JZJane Ziegler
Jane Ziegler

1 April 2018 in Topics in Clinical Nutrition
Verified
Journal Article
Closed access
AGAllison Gomes
Allison Gomes
PRPamela EdD Rothpletz-Puglia
Pamela EdD Rothpletz-Puglia
LMLaura PhD Matarese
Laura PhD Matarese
JZJane Dcn Ziegler
Jane Dcn Ziegler
The increased life expectancy seen in patients with cystic fibrosis (CF) shifts the focus of nutrition interventions from supporting survival to improving quality of life. The aim of this narrative review is to explore the importance of weight status and health-related quality of life in adults with CF. This review also identifies research supporting the differences in body image based on sex, which impacts an individual's weight status and health-related quality of life. Based on the literature, the CF care team should incorporate body image screening into clinical practice to optimize weight status and increase health-related quality of life in the adult with CF.